BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1066390)

  • 1. The use of epsilon-aminocaproic acid for the management of hemophilia in dental and oral surgery patients.
    Needleman HL; Kaban LB; Kevy SV
    J Am Dent Assoc; 1976 Sep; 93(3):586-90. PubMed ID: 1066390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epsilon aminocaproic acid in hemophiliacs undergoing dental extractions: a concise review.
    Lucas ON; Albert TW
    Oral Surg Oral Med Oral Pathol; 1981 Feb; 51(2):115-20. PubMed ID: 6782532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of epsilon-aminocaproic acid for the management of hemophilia in dental and oral surgery patients.
    Evans BE
    J Am Dent Assoc; 1977 Jan; 94(1):21. PubMed ID: 264310
    [No Abstract]   [Full Text] [Related]  

  • 5. The therapeutic role of epsilon-aminocaproic acid (EACA) for dental extractions in hemophiliacs.
    Walsh PN; Rizza CR; Evans BE; Aledort LM
    Ann N Y Acad Sci; 1975 Jan; 240():267-76. PubMed ID: 1078619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral bleeding in hemophilia: treatment with epsilon aminocaproic acid and replacement therapy.
    Corrigan JJ
    J Pediatr; 1972 Jan; 80(1):124-8. PubMed ID: 4536942
    [No Abstract]   [Full Text] [Related]  

  • 7. Epsilon-Aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: a double blind controlled trial.
    Walsh PN; Rizza CR; Matthews JM; Eipe J; Kernoff PB; Coles MD; Bloom AL; Kaufman BM; Beck P; Hanan CM; Biggs R
    Br J Haematol; 1971 May; 20(5):463-75. PubMed ID: 4931484
    [No Abstract]   [Full Text] [Related]  

  • 8. [Application of epsilon-aminocaproic acid for oral mucosal bleeding in hemophiliacs].
    Rokicka-Milewska R; Krajewska-Martel A; Dyszy-Laube B
    Pol Arch Med Wewn; 1966; 37(4):445-50. PubMed ID: 5297060
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intravenous administration of deamino-D-arginine-vasopressin (DDAVP) to patients with hemophilia A and von Willebrand's disease].
    Janczarski M; Ruszkowska I; Cetnarowicz H; Lopaciuk S
    Acta Haematol Pol; 1990; 21(1):16-21. PubMed ID: 2260405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tooth extraction in patients suffering from hemophilia A under the cover of cryoprecipitates and epsilon-aminocaproic acid].
    Pniejnia-OlszyƄski W; Pietrzykowska E; Lopaciuk S
    Acta Haematol Pol; 1979; 10(2):123-8. PubMed ID: 474045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of hemostasis during exodontia in two hemophiliacs with factor VIII inhibitors.
    Zech R; Strother SV
    J Oral Maxillofac Surg; 1983 Jan; 41(1):53-6. PubMed ID: 6217303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epsilon-aminocaproic acid therapy for dental extractions in haemophiliacs.
    Cooksey MW; Perry CB; Raper AB
    Br Med J; 1966 Dec; 2(5530):1633-4. PubMed ID: 5297046
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
    Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
    Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of epsilon aminocaproic acid as an adjunct to replacement therapy in hemophiliacs undergoing tooth extraction (part II).
    Evans BE
    N Y J Dent; 1981 Apr; 51(4):117-27. PubMed ID: 6784050
    [No Abstract]   [Full Text] [Related]  

  • 16. THE USE OF EPSILON-AMINOCAPROIC ACID IN THE MANAGEMENT OF DENTAL EXTRACTIONS IN THE HEMOPHILIAC.
    REID WO; LUCAS ON; FRANCISCO J; GEISLER PH; ERSLEV AJ
    Am J Med Sci; 1964 Aug; 248():184-8. PubMed ID: 14206770
    [No Abstract]   [Full Text] [Related]  

  • 17. Dental extractions in hemophilic patients on aminocaproic acid prophylaxis. Further experience with two additional cases.
    Giordano ND; Watkins RS; Radivoyevitch M; Goodstitt E
    Oral Surg Oral Med Oral Pathol; 1968 Aug; 26(2):160-6. PubMed ID: 5301749
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence that less replacement therapy is required for dental extractions in hemophiliacs.
    Steinberg SE; Levin J; Bell WR
    Am J Hematol; 1984 Jan; 16(1):1-13. PubMed ID: 6421150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epsilon-aminocaproic acid for synovectomy in haemophilic patients.
    Storti E; Ascari E; Turpini R; Molinari E; Gamba G; Pettene A
    Acta Haematol; 1972; 47(3):146-56. PubMed ID: 4624252
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of ambulatory oral surgical patients with hemophilia.
    Sachs SA; Lipton R; Frank R
    J Oral Surg; 1978 Jan; 36(1):25-9. PubMed ID: 271205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.